Invention Grant
![Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides](/docs/US/2024-09-03/US12077533B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
-
Application No.: US17393463Application Date: 2021-08-04
-
Publication No.: US12077533B2Publication Date: 2024-09-03
- Inventor: Atli Thorarensen , Matthew Frank Brown , Agustin Casimiro-Garcia , Ye Che , Jotham Wadsworth Coe , Mark Edward Flanagan , Adam Matthew Gilbert , Matthew Merrill Hayward , Jonathan David Langille , Justin Ian Montgomery , Jean-Baptiste Telliez , Rayomand Jal Unwalla , John I Trujillo
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent A. David Joran
- The original application number of the division: US14559294 2014.12.03
- Main IPC: A61K31/4523
- IPC: A61K31/4523 ; C07D471/04 ; C07D471/08 ; C07D487/04 ; C07D487/10 ; C07D498/04
![Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides](/abs-image/US/2024/09/03/US12077533B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides a method for treating alopecia using certain pharmaceutically active pyrrolo[2,3-d]pyrimidinyl acrylamides having the structure:
or a pharmaceutically acceptable salt thereof, as set forth in the Description.
or a pharmaceutically acceptable salt thereof, as set forth in the Description.
Public/Granted literature
- US20230009153A1 PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES Public/Granted day:2023-01-12
Information query
IPC分类:
